Pretreatment plasma renin activity levels correlate with the blood pressure response to telmisartan in essential hypertension

American Journal of Hypertension

Volumn 21, Issue 1, 2008, Pages 10-13

  Minami, Junichi ^a   Ishimitsu, Toshihiko ^a   Matsuoka, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RENIN; TELMISARTAN;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG RESPONSE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; JAPAN; MALE; OUTCOME ASSESSMENT; PLASMA RENIN ACTIVITY; PREDICTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, ORAL; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ASIAN CONTINENTAL ANCESTRY GROUP; BENZIMIDAZOLES; BENZOATES; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; RENIN; TREATMENT OUTCOME;

EID: 38349154154     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2007.15     Document Type: Article

References (15)

1. Stafford RS, Monti V, Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension 2006; 48:213-218.
2. Weinberger MH, White WB, Ruilope LM, MacDonald TM, Davidson RC, Roniker B, Patrick JL, Krause SL. Effects of eplerenone versus losartan in patients with low-renin hypertension. Am Heart J 2005; 150:426-433.
3. Fujiwara T, Katsuya T, Matsubara M, Mikami T, Ishikawa K, Kikuya M, Ohkubo T, Hozawa A, Michimata M, Suzuki M, Metoki H, Asayama K, Araki T, Tsuji I, Higaki J, Satoh H, Hisamichi S, Ogihara T, Imai Y. T+31C polymorphism of angiotensinogen gene and nocturnal blood pressure decline: the Ohasama study. Am J Hypertens 2002; 15:628-632.
4. Ishikawa K, Imai Y, Katsuya T, Ohkubo T, Tsuji I, Nagai K, Takami S, Nakata Y, Satoh H, Hisamichi S, Higaki J, Ogihara T. Human G-protein beta3 subunit variant is associated with serum potassium and total cholesterol levels but not with blood pressure. Am J Hypertens 2000; 13:140-145.
5. Takami S, Imai Y, Katsuya T, Ohkubo T, Tsuji I, Nagai K, Satoh H, Hisamichi S, Higaki J, Ogihara T. Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction. The Ohasama study. Am J Hypertens 2000; 13:121-127.
6. Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 2003; 26:521-525.
7. Ohta Y, Tsuchihashi T, Onaka U, Eto K, Tominaga M, Ueno M. Long-term compliance with salt restriction in Japanese hypertensive patients. Hypertens Res 2005; 28:953-957.
8. Minami J, Kawano Y, Ishimitsu T, Takishita S. Related blunted parasympathetic modulation in salt-sensitive patients with essential hypertension: evaluation by power-spectral analysis of heart-rate variability. J Hypertens 1997; 15:727-735.
9. Alderman MH, Cohen HW, Sealey JE, Laragh JH. Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients. Am J Hypertens 2004; 17:1-7.
10. Sealey JE, Blumenfeld J, Laragh JH. Prorenin cryoactivation as a possible cause of normal renin levels in patients with primary aldosteronism. J Hypertens 2005; 23:459-460.
11. Papademetriou V, Narayan P, Kokkinos P. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in African-American patients with hypertension. J Clin Hypertens 2004; 6:310-314.
12. White WB. Relevance of blood pressure variation in the circadian onset of cardiovascular events. J Hypertens 2003; 21(Suppl):S9-S15.
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
14. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
15. Japanese Society of Hypertension Guidelines Committee. Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006; 29(Suppl):S1-S105.